Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
J Urol ; 183(6): 2395-402, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20403623

ABSTRACT

PURPOSE: We assessed the ability of different classes of histone deacetylase inhibitors to target tumor and invasive suppressor genes in a panel of bladder carcinoma cell lines using reverse phase protein arrays. MATERIALS AND METHODS: Three poorly, moderately and highly invasive cell lines were exposed to histone deacetylase inhibitors, trichostatin A, apicidin, valproic acid (Sigma) and MS-275 (AXXORA) for 0 to 36 hours. Lysates were harvested and arrayed in a 10-fold dilution series in duplicate. Data points were collected and analyzed using a concentration interpolation methodology after normalization. RESULTS: Protein expression profiles revealed up-regulation of gamma-catenin in highly invasive lines, and alpha-catenin in moderately and highly invasive lines after exposure to all histone deacetylase inhibitors, apicidin and MS-275, respectively. Gelsolin was up-regulated in poorly and moderately invasive lines after exposure to all histone deacetylase inhibitors. Desmoglein was down-regulated in poorly and moderately invasive cell lines by all 4 histone deacetylase inhibitors, in addition to decreased FAK (Transduction Laboratories) expression in moderately and highly invasive lines exposed to valproic acid and MS-275. CONCLUSIONS: Different histone deacetylase inhibitor classes have the potential to modulate tumor and invasive suppressor gene expression, identifying histone deacetylase inhibitors as potential therapeutic agents for bladder cancer. Reverse phase protein arrays enable high throughput screening of multiple compounds to assess the expression profile of specific protein groups targeted for therapy.


Subject(s)
Gene Expression Regulation, Neoplastic/drug effects , Genes, Suppressor/drug effects , Histone Deacetylase Inhibitors/pharmacology , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/pathology , Humans , Neoplasm Invasiveness , Protein Array Analysis , Tumor Cells, Cultured
2.
Cancer Res ; 68(8): 2736-44, 2008 Apr 15.
Article in English | MEDLINE | ID: mdl-18413741

ABSTRACT

Genistein (4',5,7-trihydroxyisoflavone) is the most abundant isoflavone found in the soybean. The effects of genistein on various cancer cell lines have been extensively studied but the precise molecular mechanisms are not known. We report here the epigenetic mechanism of the action of genistein on androgen-sensitive (LNCaP) and androgen-insensitive (DuPro) human prostate cancer cell lines. Genistein induced the expression of tumor suppressor genes p21 (WAF1/CIP1/KIP1) and p16 (INK4a) with a concomitant decrease in cyclins. There was a G(0)-G(1) cell cycle arrest in LNCaP cells and a G(2)-M arrest in DuPro cells after genistein treatment. Genistein also induced apoptosis in DuPro cells. DNA methylation analysis revealed the absence of p21 promoter methylation in both cell lines. The effect of genistein on chromatin remodeling has not been previously reported. We found that genistein increased acetylated histones 3, 4, and H3/K4 at the p21 and p16 transcription start sites. Furthermore, we found that genistein treatment also increased the expression of histone acetyl transferases that function in transcriptional activation. This is the first report on epigenetic regulation of various genes by genistein through chromatin remodeling in prostate cancer. Altogether, our data provide new insights into the epigenetic mechanism of the action of genistein that may contribute to the chemopreventive activity of this dietary isoflavone and have important implications for epigenetic therapy.


Subject(s)
Chromatin/genetics , Cyclin-Dependent Kinase Inhibitor p16/genetics , Cyclin-Dependent Kinase Inhibitor p21/genetics , Genistein/pharmacology , Prostatic Neoplasms/genetics , Acetylation , Cell Cycle/drug effects , Cell Line, Tumor , Chromatin/drug effects , DNA, Neoplasm/drug effects , DNA, Neoplasm/genetics , DNA, Neoplasm/isolation & purification , Gene Expression Profiling , Genes, Suppressor/drug effects , Genes, Tumor Suppressor/drug effects , Histones/drug effects , Histones/metabolism , Humans , Male , Polymerase Chain Reaction , Prostatic Neoplasms/pathology
3.
Laryngorhinootologie ; 86(1): 9-13, 2007 Jan.
Article in German | MEDLINE | ID: mdl-17226729

ABSTRACT

In search of new targeted therapies for squamous cell carcinoma of the head neck (HNSCC), a better understanding of the carcinogenesis is of outmost importance. Recent studies show that not only genetic but also epigenetic alterations initiate the multistep process of tumordevelopment. Epigenetic changes lead to altered gene expression without alterations of the DNA sequence. The best characterized epigenetic change is the methylation of the promoter region of genes, especially of tumorsuppressor genes. The methylation of the promoter region blocks the promoter and therefore represses transcription. The loss of the gene products of tumorsuppressor genes leads to increased proliferation and decreased apoptosis. Methylation of tumorsuppressor genes was shown in precancerous lesions of HNSCC, which emphasizes the importance of methylation as an early biomarker. Several studies of tumor cell cultures show reactivated expression of proteins and as a result reduction of proliferation and induction of apoptosis after treatment with demethylating agentens. This presents a very promising new option for a targeted therapy.


Subject(s)
Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/therapy , Epigenesis, Genetic/genetics , Otorhinolaryngologic Neoplasms/genetics , Otorhinolaryngologic Neoplasms/therapy , Targeted Gene Repair/methods , Antimetabolites, Antineoplastic/pharmacology , Apoptosis/drug effects , Apoptosis/genetics , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , Carcinoma, Squamous Cell/diagnosis , Cell Division/drug effects , Cell Division/genetics , DNA Methylation/drug effects , DNA Modification Methylases/antagonists & inhibitors , Decitabine , Gene Expression Regulation, Neoplastic/physiology , Genes, Suppressor/drug effects , Otorhinolaryngologic Neoplasms/diagnosis , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , Tumor Cells, Cultured/drug effects
4.
Biochim Biophys Acta ; 1730(3): 165-72, 2005 Sep 25.
Article in English | MEDLINE | ID: mdl-16135388

ABSTRACT

An estimated one third of all inherited genetic disorders and many forms of cancer are caused by premature (nonsense) termination codons. Aminoglycoside antibiotics are candidate drugs for a large number of such genetic diseases; however, aminoglycosides are toxic, lack specificity and show low efficacy in this application. Because translational termination is an active process, we considered that steric hindrance by antisense sequences could trigger the ribosome's "default mode" of readthrough when positioned near nonsense codons. To test this hypothesis, we performed experiments using plasmids containing a luciferase reporter with amber, ochre and opal nonsense mutations within the luxB gene in Escherichia coli. The nonspecific termination inhibitors gentamicin and paromomycin and six antisense peptide nucleic acids (PNA) spanning the termination region were tested for their potential to suppress the luxB mutation. Gentamicin and paromomycin increased luciferase activity up to 2.5- and 10-fold, respectively. Two of the PNAs increased Lux activity up to 2.5-fold over control levels, with no significant effect on cell growth or mRNA levels. Thus, it is possible to significantly suppress nonsense mutations within target genes using antisense PNAs. The mechanism of suppression likely involves enhanced readthrough, but this requires further investigation. Nonsense termination in human cells may also be susceptible to suppression by antisense agents, providing a new approach to address numerous diseases caused by nonsense mutations.


Subject(s)
Codon, Nonsense , Escherichia coli/genetics , Genes, Bacterial , Genes, Suppressor , Mutation , Anti-Bacterial Agents/pharmacology , Codon, Nonsense/chemistry , Codon, Nonsense/drug effects , Codon, Nonsense/genetics , Dose-Response Relationship, Drug , Escherichia coli/growth & development , Genes, Bacterial/drug effects , Genes, Bacterial/genetics , Genes, Reporter , Genes, Suppressor/drug effects , Gentamicins/pharmacology , Luciferases/analysis , Luciferases/genetics , Mutation/drug effects , Mutation/genetics , Paromomycin/pharmacology , Plasmids , RNA, Messenger/analysis , RNA, Messenger/drug effects , RNA, Messenger/metabolism
5.
Mutat Res ; 497(1-2): 159-67, 2001 Oct 18.
Article in English | MEDLINE | ID: mdl-11525919

ABSTRACT

The mutagenicity of three nitric oxide (NO) donors, 3-morpholinosydnonimine (SIN-1), a compound generating the precursors of peroxynitrite NO and superoxide, diethylamine/NO (DEA/NO) and spermine/NO (SPER/NO), both releasing authentic NO was analyzed using Escherichia coli tester strains IC203, carrying a deletion of the oxyR gene, and its oxyR(+) parent IC188 (the alternative name of WP2 uvrA/pKM101). The OxyR protein is a redox-sensitive transcriptional activator of genes encoding antioxidant enzymes. Strains IC203 and IC188 contain error-prone DNA polymerases polV, encoded by the chromosomal umuDC genes, and polRI, encoded by mucAB genes carried by pKM101. SIN-1 was determined to be an oxidative mutagen giving a positive response only in IC203, whereas DEA/NO and SPER/NO induced similar positive responses in IC203 and IC188 and were considered as non-oxidative mutagens. The spectrum of ochre suppressors in Trp(+) revertants induced by SIN-1 in IC203 was characterized by a higher number of TA-->AT transversions and GC-->AT transitions, and a lower number of GC-->TA transversions, with respect to the untreated control. The mutagenicity of SIN-1 in IC203, probably induced by peroxynitrite through reactive derivatives, was enhanced in the presence of plumbagin (PLB), a superoxide generator. Superoxide generation by PLB, as well as formation of peroxynitrite in cells treated with SIN-1, evaluated by monitoring the oxidation, respectively, of dihydroethidium and dihydrorhodamine 123, were greater in IC203 than in IC188. Formation of peroxynitrite in IC203 treated with SIN-1 was stimulated by PLB. After treatment with DEA/NO and SPER/NO the number of revertants scored in IC188 was higher than in strains IC187, containing only polV, and IC204, deficient in both polV and polRI. For these compounds, induced suppressor revertants in IC187 and IC204 were almost exclusively GC-->AT transitions, whereas in IC188 significant levels of GC-->TA and TA-->AT transversions were also induced. Mutagenesis by both DEA/NO and SPER/NO was partially inhibited in the presence of PLB. The results show the usefulness of the new tester strain IC203 to differentiate NO-promoted mutagenic mechanisms that involve or do not involve oxygen radicals.


Subject(s)
Escherichia coli/drug effects , Escherichia coli/genetics , Molsidomine/analogs & derivatives , Mutagens/toxicity , Nitric Oxide Donors/toxicity , Superoxides/metabolism , DNA Damage , Diethylamines/toxicity , Escherichia coli/metabolism , Genes, Bacterial/drug effects , Genes, Suppressor/drug effects , Models, Genetic , Molsidomine/toxicity , Mutagenicity Tests , Naphthoquinones/toxicity , Spermine/toxicity
6.
Biol Res ; 33(1): 11-9, 2000.
Article in English | MEDLINE | ID: mdl-11021306

ABSTRACT

The present work was undertaken to characterize a suppressor gene present in a mutant strain of A. nidulans obtained with NTG (N-Methyl-N'-Nitro-N-Nitrosoguanidine). Analyses of this mutant have shown that this suppressor, designated suO1, induces phenotypic co-reversion of several auxotrophic mutations and makes the strain sensitive to aminoglycoside antibiotics and lower temperatures. suO1 has shown to be on linkage group VIII. The vegetative growth of the mutant strain is very unstable because the suppressor gene induces the production of prototrophic mitotic sectors. The strains bearing the suO1 gene produce cleistothecia containing a reduced number of viable ascospores during the sexual cycle. The segregation of the genetic markers has also been observed in the mutant strain self crossed. From the above results it may be concluded that suO1 is an informational suppressor.


Subject(s)
Aspergillus nidulans/genetics , Genes, Fungal/physiology , Genes, Suppressor/physiology , Suppression, Genetic/physiology , Anti-Bacterial Agents/pharmacology , Cold Temperature , Drug Resistance, Microbial/physiology , Genes, Fungal/drug effects , Genes, Suppressor/drug effects , Genetic Markers , Nitrosoguanidines/pharmacology , Paromomycin/pharmacology , Phenotype , Suppression, Genetic/drug effects
7.
Mutat Res ; 468(2): 173-82, 2000 Jul 10.
Article in English | MEDLINE | ID: mdl-10882894

ABSTRACT

We previously reported that the majority of base-pair substitutions induced by an endogenous mutagen, methylglyoxal, were G:C-->T:A transversions and G:C-->A:T transitions in wild-type and nucleotide excision repair (NER)-deficient (uvrA or uvrC) Escherichia coli strains. To investigate the mutation spectrum of methylglyoxal in mammalian cells and to compare the spectrum with those detected in other experimental systems, we analyzed mutations in a bacterial suppressor tRNA (supF) gene in the shuttle vector plasmid pMY189. We treated pMY189 with methylglyoxal and immediately transfected it into simian COS-7 cells. The cytotoxicity and the mutation frequency (MF) increased according to the dose of methylglyoxal. In the mutants induced by methylglyoxal, multi-base deletions were predominant (50%), followed by base-pair substitutions (35%), in which 89% of the substitutions occurred at G:C sites. Among them, G:C-->C:G and G:C-->T:A transversions were predominant. The overall distribution of methylglyoxal-induced mutations detected in the supF gene was different from that for the spontaneous mutations. These results suggest that methylglyoxal may take part in causing G:C-->C:G and G:C-->T:A transversions in vivo.


Subject(s)
COS Cells/drug effects , Genes, Suppressor/drug effects , Point Mutation/drug effects , Pyruvaldehyde/toxicity , Animals , Base Pairing/drug effects , Base Sequence , Chlorocebus aethiops , Escherichia coli/genetics , Genetic Vectors/genetics , Molecular Sequence Data , Mutagenicity Tests , Pyruvaldehyde/pharmacology , Sequence Deletion
8.
Mutat Res ; 450(1-2): 75-93, 2000 May 30.
Article in English | MEDLINE | ID: mdl-10838135

ABSTRACT

An SV40-based shuttle vector system was used to identify the types of mutational changes and the sites of mutation within the supF DNA sequence generated by the four stereoisomers of benzo[c]phenanthrene 3,4-dihydrodiol 1,2-epoxide (B[c]PhDE), by racemic mixtures of bay or fjord region dihydrodiol epoxides (DE) of 5-methylchrysene, of 5, 6-dimethylchrysene, of benzo[g]chrysene and of 7-methylbenz[a]anthracene and by two direct acting polycyclic aromatic hydrocarbon carcinogens, 7-bromomethylbenz[a]anthracene (7-BrMeBA) and 7-bromomethyl-12-methylbenz[a]anthracene (7-BrMe-12-MeBA). The results of these studies demonstrated that the predominant type of mutation induced by these compounds is the base substitution. The chemical preference for reaction at deoxyadenosine (dAdo) or deoxyguanosine (dGuo) residues in DNA, which is in general correlated with the spatial structure (planar or non-planar) of the reactive polycyclic aromatic hydrocarbon, is reflected in the preference for mutation at A&z.ccirf;T or G&z.ccirf;C pairs. In addition, if the ability to react with DNA in vivo is taken into account, the relative mutagenic potencies of the B[c]PhDE stereoisomers are consistent with the higher tumorigenic activity associated with non-planar polycyclic aromatic hydrocarbons and their extensive reaction with dAdo residues in DNA. Comparison of the types of mutations generated by polycyclic aromatic hydrocarbons and other bulky carcinogens in this shuttle vector system suggests that all bulky lesions may be processed by a similar mechanism related to that involved in replication past apurinic sites. However, inspection of the distribution of mutations over the target gene induced by the different compounds demonstrated that individual polycyclic aromatic hydrocarbons induce unique patterns of mutational hotspots within the target gene. A polymerase arrest assay was used to determine the sequence specificity of the interaction of reactive polycyclic aromatic hydrocarbons with the shuttle vector DNA. The results of these assays revealed a divergence between mutational hotspots and polymerase arrest sites for all compounds investigated, i.e., sites of mutational hotspots do not correspond to sites where high levels of adduct formation occur, and suggested that some association between specific adducts and sequence context may be required to constitute a premutagenic lesion. A site-specific mutagenesis system employing a single-stranded vector (M13mp7L2) was used to investigate the mutational events a single benzo[a]pyrene or benzo[c]phenanthrene dihydrodiol epoxide-DNA adduct elicits within specific sequence contexts. These studies showed that sequence context can cause striking differences in mutagenic frequencies for given adducts. In addition, these sequence context effects do not originate only from nucleotides immediately adjacent to the adduct, but are also modulated by more distal nucleotides. The implications of these results for mechanisms of polycyclic aromatic hydrocarbon-induced mutagenesis and carcinogenesis are discussed.


Subject(s)
Genes, Suppressor/drug effects , Mutation , Polycyclic Aromatic Hydrocarbons/toxicity , RNA, Transfer/genetics , Animals , Base Sequence , DNA/drug effects , DNA/genetics , Genetic Vectors , Humans , Molecular Sequence Data , Point Mutation , Polycyclic Aromatic Hydrocarbons/chemistry , Sequence Deletion
9.
Mutat Res ; 450(1-2): 95-105, 2000 May 30.
Article in English | MEDLINE | ID: mdl-10838136

ABSTRACT

Nitric oxide is an important bioregulatory molecule with a range of physiological functions. Nitric oxide can also react with oxygen species to produce a range of reactive nitrogen oxides that can damage DNA and lead to mutations of the DNA base sequence. The mutagenicity of a variety of reactive nitrogen oxide species and related DNA damaging agents in the supF assay are reviewed here, in the context of recent reports that relate to the nature of the DNA lesions responsible for the induced mutations. Mutations induced by nitric oxide in the supF assay are compared to those induced by N(2)O(3), nitrous acid, peroxynitrite and different reactive oxygen species. The effect of replication of the damaged pSP189 plasmid in human cells or Escherichia coli cells is also considered.


Subject(s)
Genes, Suppressor/drug effects , Mutation , Nitric Oxide/toxicity , RNA, Transfer/genetics , DNA Damage , DNA, Bacterial/drug effects , DNA, Bacterial/genetics , Escherichia coli/drug effects , Escherichia coli/genetics , Humans , Nitrates/toxicity
10.
Biol. Res ; 33(1): 11-9, 2000. ilus, tab, graf
Article in English | LILACS | ID: lil-265763

ABSTRACT

The present work was undertaken to characterize a suppressor gene present in a mutant strain of A. nidulans obtained with NTG (N-Methyl-N'-Nitro-N-Nitrosoguanidine). Analyses of this mutant have shown that this suppressor, designated suO1, induces phenotypic co-reversion of several auxotrophic mutations and makes the strain sensitive to aminoglycoside antibiotics and lower temperatures. suO1 has shown to be on linkage group VIII. The vegetative growth of the mutant strain is very unstable because the suppressor gene induces the production of prototrophic mitotic sectors. The strains bearing the suO1 gene produce cleistothecia containing a reduced number of viable ascospores during the sexual cycle. The segregation of the genetic markers has also been observed in the mutant strain self crossed. From the above results it may be concluded that suO1 is an informational suppressor.


Subject(s)
Aspergillus nidulans/genetics , Genes, Suppressor/physiology , Mutation/physiology , Anti-Bacterial Agents/pharmacology , Cold Temperature , Drug Resistance, Microbial/physiology , Genes, Suppressor/drug effects , Genetic Markers , Mutation/drug effects , Nitrosoguanidines/pharmacology , Paromomycin/pharmacology , Phenotype
11.
Mutagenesis ; 14(1): 135-40, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10474835

ABSTRACT

The mutagenicity of peroxyl radicals, important participants in lipid peroxidation cascades, was investigated using a plasmid-based mutational assay system. Double-stranded pSP189 plasmids were incubated with a range of concentrations of the water-soluble peroxyl radical generator 2,2'-azobis(2-amidinopropane) hydrochloride (AAPH). Following replication in human Ad293 cells, the plasmids were screened for supF mutations in indicator bacteria. Exposure to peroxyl radicals caused strand nicking and a decrease in transfection efficiency, which was accompanied by a significant increase in supF mutants. Each of these effects was abolished in the presence of the water-soluble vitamin E analogue Trolox. Automated sequencing of 76 AAPH-induced mutant plasmids revealed that substitutions at G:C base pairs were the most common changes, accounting for 85.5% of all identified mutations. Of these, most comprised G:C-->T:A transversions (53.5%), with lesser contributions by G:C-->A:T transitions (23.9%) and G:C-->C:G transversions (22.5%). Collectively, these data confirm our previous findings concerning the spectrum of mutations produced upon bacterial replication of peroxyl radical-damaged phage DNA and extend them by showing that such damage has mutagenic consequences during replication in more complex eukaryotic systems.


Subject(s)
Base Pairing/drug effects , Cytosine Nucleotides/metabolism , Guanine Nucleotides/metabolism , Mutation/drug effects , Peroxides/pharmacology , Plasmids/drug effects , Amidines/pharmacology , Base Pairing/genetics , Base Sequence , Cell Line, Transformed , Cytosine Nucleotides/genetics , DNA Mutational Analysis , DNA, Bacterial/drug effects , DNA, Single-Stranded/drug effects , Embryo, Mammalian , Free Radicals/pharmacology , Genes, Suppressor/drug effects , Guanine Nucleotides/genetics , Humans , Kidney/cytology , Molecular Sequence Data , Mutation/genetics , Oxidants/pharmacology , Plasmids/genetics , RNA, Transfer/drug effects , Transfection
12.
Environ Mol Mutagen ; 32(2): 173-8, 1998.
Article in English | MEDLINE | ID: mdl-9776180

ABSTRACT

Previously, we determined that elimination of deoxycytidylate (dCMP) deaminase (DCD1) in the yeast Saccharomyces cerevisiae increases the intracellular dCTP:dTTP ratio and reduces the induction of G x C --> A x T transitions in the SUP4-o gene by ethyl methanesulfonate (EMS) and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Simultaneously, the G x C --> C x G transversion frequency rises substantially. We attributed the first response to dCTP outcompeting dTTP for incorporation opposite O6-alkylguanine, and the second outcome to the increased dCTP pool causing error-prone repair of apurinic (AP) sites resulting from the removal or lability of N7-alkylguanine. To test the latter hypothesis, we used isogenic dcd1 strains deleted for either of two genes (MAG1: 3-methyladenine glycosylase; APN1: apurinic endonuclease) involved in the repair of N7-alkylguanine. In these backgrounds, EMS or MNNG induction of total SUP4-o mutations, G x C --> A x T transitions and G x C --> C x G transversions were reduced by >98%, >97%, and >80%, respectively. Mutation frequencies in the dcd1 apn1 strain were close to those for spontaneous mutagenesis in the wild-type parent. These findings argue that misincorporation of dCTP during repair of alkylation-induced AP sites is responsible for the increased G x C --> C x G transversion frequency in the dcd1 strain treated with EMS or MNNG. The data also demonstrate that defective repair of AP sites coupled with an elevated dCTP:dTTP ratio eliminates most EMS and MNNG mutagenesis. In addition, the results point to a role for AP sites in the production of some EMS- and MNNG-induced G x C --> A x T transitions as well as other substitutions in the dcd1 strain.


Subject(s)
Alkylating Agents/toxicity , Carbon-Oxygen Lyases/physiology , DNA Glycosylases , DNA Ligases/physiology , DNA Repair , DNA, Fungal/drug effects , Deoxycytosine Nucleotides/pharmacology , Ethyl Methanesulfonate/antagonists & inhibitors , Fungal Proteins/physiology , Methylnitronitrosoguanidine/toxicity , Mutagenesis/drug effects , N-Glycosyl Hydrolases/physiology , Saccharomyces cerevisiae/drug effects , Alkylation , Carbon-Oxygen Lyases/deficiency , Carbon-Oxygen Lyases/genetics , DNA Adducts/metabolism , DNA Damage , DNA Ligases/deficiency , DNA Ligases/genetics , DNA Repair/drug effects , DNA Repair/genetics , DNA, Fungal/genetics , DNA, Fungal/metabolism , DNA-(Apurinic or Apyrimidinic Site) Lyase , Deoxyribonuclease IV (Phage T4-Induced) , Ethyl Methanesulfonate/toxicity , Fungal Proteins/genetics , Genes, Suppressor/drug effects , Intracellular Fluid , N-Glycosyl Hydrolases/deficiency , N-Glycosyl Hydrolases/genetics
13.
Rocz Panstw Zakl Hig ; 49(1): 35-54, 1998.
Article in Polish | MEDLINE | ID: mdl-9734231

ABSTRACT

In this review recent point of view concerning the molecular mechanisms of chemically induced carcinogenesis is presented. The new and promising trends of neoplasia investigations are based on discovery of protooncogenes and tumor suppressor genes, which maintain tissue homeostasis by controlling cellular proliferation and differentiation. It is generally recognised, that mutations induced by genotoxic carcinogens, particularly those resulting in activation of protooncogenes and inactivation of suppressor genes, play a crucial role in the initiation step of multistage process of tumorigenesis. Tumor promotion is recognized as a process whereby initiated cells are stimulated to selective growth and then, to develop into the cancer during progression step. Tumor promotion can be affected by many nongenotoxic carcinogens. In this review the attention is given to the mutational activation of the c-ras oncogenes and inactivation of p53 suppressor gene in rodent and human cancers by genotoxic carcinogens. Moreover, the significance of nongenotoxic carcinogens and the mechanisms by which these compounds may accelerate tumorigenesis are discussed.


Subject(s)
Carcinogens , Neoplasms, Experimental/chemically induced , Animals , Carcinogens/pharmacology , Cell Transformation, Neoplastic/drug effects , Disease Models, Animal , Genes, Suppressor/drug effects , Humans , Mutation , Neoplasms, Experimental/physiopathology , Proto-Oncogenes/drug effects , Signal Transduction/drug effects
14.
Chem Res Toxicol ; 11(3): 211-6, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9544619

ABSTRACT

Cadmium is a toxic environmental contaminant that is carcinogenic in humans and rodents. Although cadmium has proven to be mutagenic in a variety of assay systems, exactly how cadmium achieves gentoxicity is poorly understood. To define the mechanism(s) underlying the mutagenicity and comutagenicity of cadmium, human Ad293 cells were exposed to subtoxic doses of the metal and transfected with untreated or anti-5-methylchrysene-3,4-dihydrodiol 1,2-epoxide (5-MCDE)-treated pS189 shuttle vector. Alterations in the frequency, types, and distribution of mutations were subsequently assessed in the supF gene of pS189 that was replicated in Ad293 cells and screened in indicator bacteria. Doses of 0.5 and 1 microM CdCl2 increased the mutation frequency of untreated pS189 by approximately 4- and 8-fold, respectively, with no apparent effect on the types of mutations generated. In contrast, host-cell exposure to cadmium had little or no effect on the frequency, types, or distribution of mutations generated with 5-MCDE-treated pS189. These results indicate that cadmium increases mutagenesis of untreated pS189 by affecting a process that is not involved in mutagenesis of the 5-MCDE-treated vector. Although it is not clear exactly how host-cell exposure to cadmium increases background mutagenesis, presumably, the mutagenic effect does not involve cadmium interaction with the cellular machinery used to replicate past bulky DNA lesions.


Subject(s)
Cadmium/toxicity , Carcinogens/toxicity , Chrysenes/toxicity , Genes, Suppressor/drug effects , Mutagenesis/drug effects , Plasmids/genetics , RNA, Transfer/genetics , Base Sequence , Cell Line , Drug Synergism , Humans , Molecular Sequence Data , Plasmids/drug effects , Point Mutation/drug effects , Transfection/drug effects
15.
Curr Genet ; 33(1): 21-8, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9472076

ABSTRACT

The fungal metabolite Brefeldin A (BFA) disrupts the Golgi apparatus and its incoming protein flux. We developed a genetic approach to identify yeast proteins involved in the protein transport step that BFA blocks. The BFR2 gene (YDR299W) was thus isolated as a high-copy suppressor of the growth defects induced by BFA in a sensitive strain of Saccharomyces cerevisiae. Although BFR2 over-expression did not cause a secretory block or slow-down, it partially suppressed the growth defect of four mutants blocked at the step of budding or docking of small vesicles en route to the Golgi (sec13-1, sec16-2, sec23-1, ypt1-1). The essential BFR2 gene was predicted to encode an extremely hydrophilic product containing two short regions with potential coiled-coils, one of which corresponds to a cluster of acidic residues.


Subject(s)
Cyclopentanes/pharmacology , Endoplasmic Reticulum/genetics , Gene Expression Regulation, Fungal/drug effects , Genes, Suppressor/drug effects , Golgi Apparatus/genetics , Receptors, Fibroblast Growth Factor/genetics , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/genetics , Antifungal Agents/pharmacology , Brefeldin A , Endoplasmic Reticulum/metabolism , Genes, Fungal/drug effects , Golgi Apparatus/metabolism , Mutation , Nystatin/pharmacology , Organelles/genetics , Organelles/metabolism , Receptors, Fibroblast Growth Factor/biosynthesis , Saccharomyces cerevisiae/drug effects
16.
Environ Mol Mutagen ; 30(1): 65-71, 1997.
Article in English | MEDLINE | ID: mdl-9258331

ABSTRACT

Forward mutations induced by 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the supF gene of Escherichia coli were recovered from bacteria deficient in nucleotide excision repair and in DNA-alkyltransferase activity. Bacteria were exposed to 0.4 mM CCNU (in vivo supF mutagenesis), increasing the overall mutation frequency 15.7-fold above the spontaneous value. A total of 73 independent supF- mutants were sequenced. The resulting mutation spectrum was compared with those obtained in bacteria and mammalian cells following the classical shuttle-vector approach (in vitro supF mutagenesis). In vivo CCNU mutagenesis in E. coli yielded a large number of deletions (20/73), in agreement with mammalian data but distinct from in vitro bacterial spectra, which are almost exclusively composed of G:C-->A:T transitions. A substantial proportion (6/18) of CCNU-induced deletions (> 3 bp) involved repeated DNA sequences, suggesting a contribution of a slippage-misalignment process in the generation of this mutation class. Substitutions occurred primarily at G:C base pairs (44/53) and were predominantly G:C-->A:T transitions (39/53). This mutational change was attributed to the mispair potential of the O6-chloroethylguanine lesion with thymine. Most G:C-->A:T transitions (34/39) were located at three 5'-GG-3' hotspot sites (positions 123, 160, and 168). The distribution of hotspot sites for G:C-->A:T substitutions differed as a function of the in vivo or in vitro chemical modification of the supF-bearing plasmids and revealed significant differences in the DNA strand distribution of this mutational event. Our data suggest that the transcriptional status of the target gene has strong influence on the probability of O6-chloroethylguanine formation, reducing its incidence in the transcribed DNA strand.


Subject(s)
DNA, Bacterial/drug effects , Escherichia coli/genetics , Genes, Bacterial/drug effects , Genes, Suppressor/genetics , Lomustine/toxicity , Mutagenesis/drug effects , Mutagens/toxicity , RNA, Transfer/genetics , Base Composition/drug effects , Base Sequence/drug effects , DNA Mutational Analysis , DNA, Bacterial/genetics , Escherichia coli/drug effects , Genes, Suppressor/drug effects , Molecular Sequence Data , Plasmids/drug effects , RNA, Transfer/drug effects
17.
Mutat Res ; 349(1): 51-61, 1996 Jan 17.
Article in English | MEDLINE | ID: mdl-8569792

ABSTRACT

Peroxynitrite is a powerful oxidant formed through reaction of nitric oxide with superoxide. Because activated macrophages can produce both nitric oxide and superoxide, it has been proposed that peroxynitrite may contribute to cytotoxicity and increased cancer risks associated with the inflammatory response during chronic infections. We therefore investigated mutagenicity of peroxynitrite in the supF gene of the pSP189 shuttle vector as a mutation target. The plasmid was exposed to 2.5 mM peroxynitrite in vitro, then replicated in Eschericia coli MBL50 and in human AD293 cells. Mutation frequency increased 21-fold in pSP189 replicated in E. coli and 9-fold in plasmid replicated in human cells. Mutations were clustered within the 5' region of the supF gene in plasmids replicated in bacteria. The hot spots were located at positions 108, 113, 116, 124, 126 and 141; more than 25% of all mutations occurred at position 124. Following replication in human cells, mutations were more widely distributed over the gene, with hot spots at positions 113, 124, 133, 156 and 164; 15% occurred at position 124. In both systems, the majority of mutations occurred at G:C base pairs, predominantly involving G:C-->T:A transversions (65% when replication was in bacteria and 63% when in human cells). G:C-->C:G transversions were observed at lower frequency (28% in MBL50 and 11% in AD293 cells), and 11% of mutations found in vectors replicated in AD293 cells were G:C-->A:T transitions. A greater number of large deletions, insertions, tandem and multiple mutations occurred in plasmid replicated in AD293 cells. Differences in mutation spectra following replication in the two systems may be attributable to differences in recognition and repair of the lesions and/or properties of the replication apparatus.


Subject(s)
Genes, Suppressor/drug effects , Genetic Vectors/drug effects , Mutagens/toxicity , Nitrates/toxicity , Oxidants/toxicity , RNA, Transfer/genetics , Base Sequence , Cell Line , DNA Replication , DNA, Recombinant , Escherichia coli/genetics , Genetic Vectors/genetics , Humans , Molecular Sequence Data , Mutagenicity Tests
18.
Mutat Res ; 327(1-2): 113-20, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7532787

ABSTRACT

The mutagenicity of the antitumor drug dacarbazine (DTIC) is due to alkylation of cellular DNA by metabolites resulting from the metabolism of this drug by the mixed function oxidase system. In the present study, we used an in vitro shuttle vector assay to study the base and sequence specificity of mutagenesis by DTIC. The shuttle vector plasmid pSP189 was treated with DTIC (1-2.5 mM) in vitro in a reconstituted cytochrome P-450 system at 37 degrees C for either 30 or 60 min. SupF tRNA gene insert contained in the plasmid was sequenced after replication of the drug-treated plasmid in human Ad 293 cells followed by amplification in indicator bacteria. Mutagenesis of DTIC in this system was dependent upon the presence of the cytochrome P-450 reconstituted system and NADPH. Mutations induced by DTIC included single base substitutions (35%), single base deletions (30.5%), single base insertions (19.4%) and large deletions (13.8%). Among the substitutions, transversions and transitions were in the ratio of 1:0.7. Base pairs 108 and 127 in the SupF tRNA of the pSP189 were identified as mutational hot spots.


Subject(s)
Cytochrome P-450 Enzyme System/metabolism , Dacarbazine/pharmacokinetics , Genes, Reporter/drug effects , Genetic Vectors/drug effects , Mutagenesis , Mutation , Prodrugs/pharmacokinetics , Biotransformation , Cell Line, Transformed , Cell-Free System , Dacarbazine/metabolism , Dacarbazine/toxicity , Escherichia coli/genetics , Genes, Suppressor/drug effects , Genetic Vectors/genetics , Humans , Hydroxylation , Kidney , Methylation , Microsomes, Liver/enzymology , NADP/physiology , Point Mutation , RNA, Bacterial/genetics , RNA, Transfer/genetics , Sequence Deletion
19.
Mol Gen Genet ; 243(5): 500-5, 1994 Jun 03.
Article in English | MEDLINE | ID: mdl-8208241

ABSTRACT

A vector plasmid, pZ189, carrying an Escherichia coli supF gene as a target for mutations, was treated with a combination of hydrogen peroxide and Fe3+/EDTA complex and propagated in E. coli host cells that had been induced for SOS functions by ultraviolet irradiation. The mutations frequency increased by up to 30-fold over spontaneous background levels with increasing concentrations of hydrogen peroxide. The increase in mutation frequency correlated with an increase in the formation of 8-hydroxydeoxyguanosine in the pZ189 DNA. Sequence analysis of 82 independent supF mutant plasmids revealed that 70 mutants contained base substitutions, with 63 of the 70 involving a G:C base pair, and with G:C-->C:G (28 cases) and G:C-->T:A (26 cases) transversions predominating. Investigation of the influence of the local DNA sequence on the transversions revealed that the guanine at the center of the triplet 5'-PuGA-3' was five times more likely to mutate after treatment with hydrogen peroxide than that at the center of 5'PyGN3'. G:C-->T:A transversions presumably resulted from mispairing of an altered G (probably 8-hydroxydeoxyguanosine) with deoxyadenosine. The origin of the G:C-->C:G transversions may be an as yet unidentified lesion generated by hydrogen peroxide. Mutagenic hotspots for base substitutions were found at positions 133, 160 and 168. Mutation spectra and the positions of mutagenic hotspots, when compared with a previously determined spontaneous mutagenesis spectrum, also provide information on the mechanism of spontaneous mutagenesis.


Subject(s)
Escherichia coli/drug effects , Genes, Bacterial/drug effects , Genes, Suppressor/drug effects , Hydrogen Peroxide/toxicity , Point Mutation , 8-Hydroxy-2'-Deoxyguanosine , Base Sequence , DNA Damage , DNA Mutational Analysis , DNA, Bacterial/genetics , DNA, Bacterial/metabolism , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/biosynthesis , Dose-Response Relationship, Drug , Escherichia coli/genetics , Molecular Sequence Data , Oxidation-Reduction , Plasmids
20.
Carcinogenesis ; 13(10): 1783-7, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1423838

ABSTRACT

Benzoyl peroxide (BzPO) enhances tumor promotion and malignant conversion in mouse epidermis. DNA damage may contribute to these processes. BzPO reacts with Cu(I) to produce the benzoyloxyl radical, which in turn causes strand breaks in plasmid DNA. In this study we investigated whether BzPO with or without Cu(I) caused promutagenic DNA damage in the supF gene of the mutation reporter plasmid pS189 replicating in human Ad293 cells. Exposure of pS189 in vitro to BzPO (0.1-1 mM) inhibited plasmid replication; however, addition of Cu(I) (0.1 mM) did not augment BzPO-induced plasmid toxicity. Exposure to BzPO with or without 0.1 mM Cu(I) was also associated with a concentration-dependent increase in mutation frequency, up to > 100-fold above the spontaneous mutation frequency. Supplemental Cu(I) was not required for mutagenesis; however, it both raised the maximal mutation frequency observed and lowered the threshold concentration of BzPO necessary to discern mutagenesis above the spontaneous background. Neither the hydroxyl radical scavengers mannitol or DMSO, the spin trap N-tert-butyl-alpha-phenylnitrone, nor reduced glutathione altered BzPO/Cu(I)-induced mutagenesis; however, mutagenesis was suppressed by the chelator EDTA. Twenty-four of 32 individual BzPO/Cu(I)-induced mutants characterized by sequencing contained point mutations; 22/25 point mutations occurred at G-C base pairs. There were five large deletions and four small deletions. Three additional BzPO-induced mutants contained four point mutations, all occurring at G-C base pairs. Two BzPO/Cu(I)-induced mutational clusters at d(pGGG)-d(pCCC) sites were observed. These data suggest that BzPO may interact with Cu(I) bound to G-C base pairs in DNA to produce site-specific promutagenic DNA damage.


Subject(s)
Benzoyl Peroxide/toxicity , Copper/toxicity , DNA Damage , Genes, Suppressor/genetics , Mutagenesis, Site-Directed/drug effects , Plasmids/genetics , Base Sequence , Cells, Cultured , Chromosome Mapping , Copper/metabolism , DNA/metabolism , DNA Replication/drug effects , Dimethyl Sulfoxide/pharmacology , Genes, Suppressor/drug effects , Humans , Kinetics , Mannitol/pharmacology , Molecular Sequence Data , Mutagenesis, Site-Directed/genetics , Mutation , Plasmids/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...